CEFDINIR

N/A

Manufactured by American Health Packaging

15,428 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CEFDINIR

CEFDINIR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by American Health Packaging. The most commonly reported adverse reactions for CEFDINIR include DIARRHOEA, CHRONIC KIDNEY DISEASE, PNEUMONIA, FATIGUE, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CEFDINIR.

Top Adverse Reactions

DIARRHOEA509 reports
CHRONIC KIDNEY DISEASE485 reports
PNEUMONIA466 reports
FATIGUE443 reports
NAUSEA383 reports
PAIN367 reports
RENAL FAILURE360 reports
SINUSITIS349 reports
ACUTE KIDNEY INJURY324 reports
HEADACHE315 reports
DYSPNOEA314 reports
URINARY TRACT INFECTION288 reports
DEATH286 reports
PYREXIA280 reports
RASH273 reports
DRUG INEFFECTIVE272 reports
OFF LABEL USE270 reports
COUGH254 reports
VOMITING253 reports
ANXIETY230 reports
DRUG HYPERSENSITIVITY229 reports
PRODUCT DOSE OMISSION ISSUE221 reports
ASTHENIA217 reports
ARTHRALGIA205 reports
DIZZINESS204 reports
MALAISE193 reports
FALL179 reports
WEIGHT DECREASED171 reports
PRURITUS166 reports
CONSTIPATION165 reports
URTICARIA161 reports
COVID 19160 reports
DECREASED APPETITE157 reports
NASOPHARYNGITIS152 reports
PAIN IN EXTREMITY149 reports
BRONCHITIS148 reports
END STAGE RENAL DISEASE148 reports
INFECTION140 reports
INSOMNIA137 reports
ABDOMINAL PAIN133 reports
BACK PAIN132 reports
PERIPHERAL SWELLING131 reports
ANAEMIA128 reports
HYPERSENSITIVITY127 reports
CONDITION AGGRAVATED126 reports
NO ADVERSE EVENT125 reports
EMOTIONAL DISTRESS121 reports
ILLNESS119 reports
DEPRESSION117 reports
UPPER RESPIRATORY TRACT INFECTION117 reports
EAR INFECTION115 reports
INFLUENZA110 reports
ABDOMINAL PAIN UPPER109 reports
FEELING ABNORMAL108 reports
MUSCLE SPASMS108 reports
HYPOTENSION102 reports
RENAL INJURY102 reports
CHEST PAIN99 reports
ABDOMINAL DISCOMFORT97 reports
SEPSIS96 reports
ASTHMA94 reports
NEPHROGENIC ANAEMIA92 reports
PLATELET COUNT DECREASED90 reports
GASTROOESOPHAGEAL REFLUX DISEASE87 reports
DEHYDRATION86 reports
CHILLS85 reports
GAIT DISTURBANCE85 reports
PRODUCT STORAGE ERROR85 reports
HYPERTENSION82 reports
OEDEMA PERIPHERAL81 reports
ERYTHEMA80 reports
CHEST DISCOMFORT78 reports
ALOPECIA77 reports
ANHEDONIA77 reports
WEIGHT INCREASED76 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION75 reports
PRODUCT USE IN UNAPPROVED INDICATION75 reports
SEIZURE75 reports
WHITE BLOOD CELL COUNT DECREASED75 reports
HOSPITALISATION74 reports
PRODUCTIVE COUGH74 reports
MIGRAINE73 reports
SOMNOLENCE73 reports
PRODUCT USE ISSUE72 reports
NEUROPATHY PERIPHERAL71 reports
ECONOMIC PROBLEM70 reports
FAECES DISCOLOURED70 reports
ATRIAL FIBRILLATION68 reports
BLOOD PRESSURE INCREASED68 reports
HYPOAESTHESIA68 reports
MYALGIA68 reports
HAEMOGLOBIN DECREASED67 reports
REBOUND ACID HYPERSECRETION67 reports
OROPHARYNGEAL PAIN66 reports
THROMBOSIS65 reports
DEEP VEIN THROMBOSIS64 reports
PALPITATIONS64 reports
RESPIRATORY TRACT INFECTION64 reports
ABDOMINAL DISTENSION61 reports
BLOOD GLUCOSE INCREASED61 reports

Report Outcomes

Out of 7,347 classified reports for CEFDINIR:

Serious 63.0%Non-Serious 37.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female4,236 (63.5%)
Male2,427 (36.4%)
Unknown5 (0.1%)

Reports by Age

Age 71106 reports
Age 6599 reports
Age 7097 reports
Age 5995 reports
Age 6494 reports
Age 6991 reports
Age 7291 reports
Age 6188 reports
Age 6688 reports
Age 6286 reports
Age 6782 reports
Age 6379 reports
Age 7679 reports
Age 7779 reports
Age 5778 reports
Age 6878 reports
Age 7377 reports
Age 6075 reports
Age 5274 reports
Age 5671 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CEFDINIR?

This profile reflects 15,428 FDA FAERS reports that mention CEFDINIR. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CEFDINIR?

Frequently reported terms in FAERS include DIARRHOEA, CHRONIC KIDNEY DISEASE, PNEUMONIA, FATIGUE, NAUSEA, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CEFDINIR?

Labeling and FAERS entries often list American Health Packaging in connection with CEFDINIR. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.